Back
AnGes, Inc. 10K Form
Sell
41
AMGXF
AnGes, Inc.
Last Price:
$0.36
Seasonality Move:
-8.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMGXF News And Ratings
See the #1 stock for the next 7 days that we like better than AMGXF
AMGXF Financial Statistics
Sales & Book Value
| Annual Sales: | $5.8M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.05 |
| Price / Book: | 7.09 |
Profitability
| EPS (TTM): | -0.10000 |
|---|---|
| Net Income (TTM): | $-34.7M |
| Gross Margin: | $2.1M |
| Return on Equity: | -162.7% |
| Return on Assets: | -92.81% |
AnGes, Inc. Earnings Forecast
Key AnGes, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for AMGXF is 36.65%.
-
The Selling, General & Administrative Expenses for AMGXF have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 406.48% of Revenue.
-
The Net Earning history of AMGXF is -586.10% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
AnGes, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGXF |
| Website: | anges.co.jp |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 1.96 |
| Quick Ratio: | 0.89 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AMGXF Technical Analysis vs Fundamental Analysis
Sell
41
AnGes, Inc. (AMGXF)
is a Sell
Is AnGes, Inc. a Buy or a Sell?
-
AnGes, Inc. stock is rated a SellThe current AnGes, Inc. [AMGXF] share price is $0.36. The Score for AMGXF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.